[Role of chemical cytostatic treatment in therapy of hemopathies producing chronic malignant conditions].
D005021:Ethylamines / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D008223:Lymphoma / Q000628:therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D008466:Mechlorethamine; D009369:Neoplasms; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D012509:Sarcoma
D005021:Ethylamines; D009588:Nitrogen Mustard Compounds; D008466:Mechlorethamine
ETHYLAMINES/therapeutic use; HODGKIN'S DISEASE/therapy; LEUKEMIA/therapy; LYMPHOMA/therapy; NITROGEN MUSTARDS/therapeutic use; SARCOMA, RETICULUM CELL/therapy
La posizione dei trattamenti chimici citostatici nella terapia delle emopatie produttive maligne croniche.